Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Collaboration entities : Iqvia holdings, inc. save search
IQVIA Builds on its Strategic Collaboration with argenx to Provide Safety Systems and Services
Published: 2023-10-03 (Crawled : 16:00) - biospace.com/
IQV | $227.25 -0.83% -0.15% 1.2K
|
Health Services
|
| O: -0.68%
H: 0.87%
C: -0.95%
services collaboration
IQVIA in Collaboration with Alibaba Cloud to Deliver Commercial & Clinical Solutions in China
Published: 2023-01-31 (Crawled : 15:20) - biospace.com/
IQV | $227.25 -0.83% -0.15% 1.2K
|
Health Services
|
| O: 0.27%
H: 1.21%
C: 1.11%
solutions collaboration commercial china cloud
Q² Solutions Launches Innovative Self-Collection Safety Lab Panel in Collaboration With Tasso
Published: 2022-10-06 (Crawled : 19:00) - biospace.com/
IQV | $227.25 -0.83% -0.15% 1.2K
|
Health Services
|
| O: -0.63%
H: 0.54%
C: -1.96%
solutions collaboration
IQVIA and NRx Pharmaceuticals Collaborate on Potential Medical Support for Novel COVID-19 Treatment
Published: 2021-09-13 (Crawled : 23:00) - biospace.com/
NRXP | News 0 d | $4.18 -2.79% -3.12% 91K
|
Manufacturing
|
| O: 0.0%
H: 0.25%
C: -8.88%
IQV | $227.25 -0.83% -0.15% 1.2K
|
Health Services
|
| O: 0.63%
H: 0.15%
C: -2.51%
covid treatment potential collaboration covid-19
IQVIA Collaborates with HealthCore to Advance Clinical Research Using Real-World Data
Published: 2021-09-08 (Crawled : 13:00) - biospace.com/
IQV | $227.25 -0.83% -0.15% 1.2K
|
Health Services
|
| O: -0.06%
H: 0.38%
C: -0.9%
research collaboration
Q2 Solutions and Tasso Collaborate to Provide Unique Solutions for Patients to Accelerate Adoption of Decentralized Clinical Trials
Published: 2021-06-08 (Crawled : 20:00) - biospace.com/
IQV | $227.25 -0.83% -0.15% 1.2K
|
Health Services
|
| O: 0.36%
H: 0.71%
C: 0.33%
unique clinical trials trial collaboration
IQVIA Collaborating with Janssen Research & Development on Their Investigational COVID-19 Vaccine Trials
Published: 2021-03-08 (Crawled : 14:00) - biospace.com/
IQV | $227.25 -0.83% -0.15% 1.2K
|
Health Services
|
| O: 1.42%
H: 1.82%
C: -1.92%
covid vaccine research trial collaboration covid-19
IQVIA and Servier Collaborate to Reinvent Clinical Development
Published: 2020-12-16 (Crawled : 17:00) - biospace.com/
IQV | $227.25 -0.83% -0.15% 1.2K
|
Health Services
|
| O: 0.0%
H: 1.76%
C: 1.32%
collaboration
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 49.67% 1.4M
|
Health Technology
WISA 4 | $9.25 51.64% 34.27% 64M
|
Electronic Technology
HOLO | $2.24 -5.49% 27.74% 7.7M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
CTM | $0.2201 -2.31% 22.67% 48K
|
n/a
VIAO | $0.262 0.77% 16.03% 14M
|
Electronic Technology
DXF | $0.2708 -5.71% 14.48% 190K
|
Finance
GRFX | $0.2159 -10.04% 12.55% 5.9K
|
n/a
BHIL | $0.1722 -3.8% 12.08% 290K
|
Agriculture, Forestry, Fishing ...
MCW 4 | $6.49 -1.22% 10.94% 6
|
Professional, Scientific, and T...
Your saved searches
Save your searches and get alerts when important news are released.